Gene: CWF19L1
Official Full Name: CWF19 like cell cycle control factor 1provided by HGNC
Gene Summary: This gene encodes a member of the CWF19 protein family. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia-17 and mild cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20625 | CWF19L1 Knockout cell line (HeLa) | Human | CWF19L1 | 1:3~1:6 | Negative | Online Inquiry |
KO20626 | CWF19L1 Knockout cell line (HCT 116) | Human | CWF19L1 | 1:2~1:4 | Negative | Online Inquiry |
KO20627 | CWF19L1 Knockout cell line (HEK293) | Human | CWF19L1 | 1:3~1:6 | Negative | Online Inquiry |
KO20628 | CWF19L1 Knockout cell line (A549) | Human | CWF19L1 | 1:3~1:4 | Negative | Online Inquiry |
CWF19L1 Gene Knockout Cell Lines are genetically engineered cell lines characterized by the complete disruption of the CWF19L1 gene, known to play a critical role in RNA splicing and cellular stress responses. These cell lines provide researchers with powerful tools to study the functional consequences of CWF19L1 gene deficiency, offering insights into numerous biological processes and the molecular underpinnings of various diseases.
The primary function of CWF19L1 Gene Knockout Cell Lines is to facilitate comparative studies of gene expression, cellular proliferation, and phenotypic responses under genotoxic stress conditions. The knockout mechanism typically involves CRISPR-Cas9 technology or other genome-editing techniques that ensure precise and efficient gene disruption. By using these cell lines, researchers can delve into the pathways influenced by CWF19L1, allowing for a better understanding of its role in cellular mechanisms and its implications in disorders such as cancer and neurodegenerative diseases.
Scientifically, these cell lines hold significant importance in both basic and applied research. Their applications extend from elucidating gene function to developing therapeutic strategies targeting splicing-related pathologies. As more researchers focus on the molecular profiling of diseases, the demand for specific knockout models, such as those for CWF19L1, continues to rise.
What sets CWF19L1 Gene Knockout Cell Lines apart from alternative products is their validated utility and specificity in studying the distinct functions of the CWF19L1 gene. Unlike generic cell lines, these are tailored to elucidate targeted biological pathways, presenting a unique opportunity for nuanced research findings. Furthermore, their consistent performance in various assays — including cell viability, apoptosis, and drug response — underscores their reliability for complex scientific inquiries.
For researchers, clinicians, and pharmaceutical developers, the value of CWF19L1 Gene Knockout Cell Lines lies in their ability to foster advances in understanding gene function and disease mechanisms, paving the way for innovative therapeutic developments. Backed by our company’s extensive expertise in gene editing technology and commitment to providing high-quality biological products, we offer these knockout cell lines as robust tools to enhance your research endeavors and contribute to impactful scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.